• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS Back to Search Results
Model Number VTICM5_12.6
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Endophthalmitis (1835)
Event Date 02/21/2024
Event Type  Injury  
Manufacturer Narrative
H6 - type of investigation - lens work order search: no similar complaint type events reported for units within the same lot.Manufacturer narrative: a review of the device labeling was completed.Endophthalmitis is identified in the labeling as a potential adverse event following icl implantation.Per the directions for use complications and adverse reactions implantation of any evo|evo+ icl may include but are not limited to: intraocular infection and secondary surgical intervention to remove/replace the lens.The dfu states a caution: staar surgical evo|evo+ ticl and disposable accessories are packaged and sterilized for single use only.Cleaning, reuse and/or resterilization are not applicable to these devices.If one of these devices were reused after cleaning and/or resterilization, it is highly probable that it would be contaminated, and the contamination could result in infection and/or inflammation.An exact cause could not be determined as the event could be multifactorial in nature including patient and/or procedure related factors.The lens was explanted and returned.Claim# (b)(4).
 
Event Description
The reporter indicated that a 12.6mm vticm5 implantable collamer lens of -10.50/+1.50/100 power was implanted into the patients left eye (os) on (b)(6) 2024.Postop ciproxacino and maxidex drops were given.On (b)(6) 2024 the lens was explanted due to observation of endophthalmitis.Anterior chamber wash and intravitreal corticosteroid/antibiotic treatment occurred.Oral antibiotics were also given.Diagnostic cultures were performed with lab results negative for organisms.There is no report of loss of visual acuity.On (b)(6) 2024 it was reported the patient has a suture in place and was doing well.The patient will undergo icl reimplantation two months later.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Type of Device
PHAKIC TORIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SUGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
joselene muniz
1911 walker avenue
monrovia, CA 91016
MDR Report Key18984029
MDR Text Key338659013
Report Number2023826-2024-01347
Device Sequence Number1
Product Code QCB
UDI-Device Identifier00840311308118
UDI-Public00840311308118
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P030016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberVTICM5_12.6
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/19/2024
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/26/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured12/07/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CARTRIDGE MODEL: SFC-45 W/FTP, LOT# UNK; INJECTOR MODEL: MSI-PF, LOT# UNK
Patient Outcome(s) Required Intervention;
Patient Age28 YR
Patient SexFemale
-
-